This animation shows modeled outputs from the CDA Bright (HCV) model using country-level empirical data (where available) from 2015 through 2019. 2020-2030 data are forecast in the CDA Bright model using trends in future diagnosis and treatment. Prevalence and total viremic infections represent beginning of year values (i.e. January 1).

This animation shows modeled outputs from the CDA Bright (HCV) model using country-level empirical data (where available) from 2015 through 2019. 2020-2030 data are forecast in the CDA Bright model using trends in future diagnosis and treatment. Prevalence and total viremic infections represent beginning of year values (i.e. January 1).

This animation shows modeled outputs from the PRoGReSs model using country-level empirical data (where available) from 2016 through 2019. 2020-2030 data are forecast in the PRoGReSs assuming constant diagnosis, treatment, and prophylaxes in the future. Prevalence and total infections represent beginning of year values (i.e. January 1).

This animation shows modeled outputs from the PRoGReSs model using country-level empirical data (where available) from 2016 through 2019. 2020-2030 data are forecast in the PRoGReSs assuming constant diagnosis, treatment, and prophylaxes in the future. Prevalence and total infections represent beginning of year values (i.e. January 1).

This animation shows modeled outputs from the PRoGReSs model using country-level empirical data (where available) from 2016 through 2019. 2020-2030 data are forecast in the PRoGReSs assuming constant diagnosis, treatment, and prophylaxes in the future. Prevalence and total infections represent beginning of year values (i.e. January 1).

This animation shows modeled outputs from the PRoGReSs model using country-level empirical data (where available) from 2016 through 2019. 2020-2030 data are forecast in the PRoGReSs assuming constant diagnosis, treatment, and prophylaxes in the future. Prevalence and total infections represent beginning of year values (i.e. January 1).

Last updated: April 20th, 2020